ID: MRFR/HC/9129-HCR | June 2021 | Region: Global | 120 Pages
TABLE OF CONTENTS
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Product
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterβs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL MICROCATHETERSMARKET, BY DESIGN
6.1. Overview
6.2. Single Lumen
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
6.3. Double Lumen
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7. GLOBAL MICROCATHETERSMARKET, BY PRODUCT
7.1. Overview
7.2. Aspiration Microcatheter
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7.3. Delivery Microcatheter
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7.4. Diagnostic Microcatheter
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
7.5. Steerable Microcatheter
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8. GLOBAL MICROCATHETERS MARKET, BY APPLICATION
8.1. Overview
8.2. Cardiovascular
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.3. Neurovascular
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.4. Peripheral Vascular
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.5. Oncology
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
8.6. Urology
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
9. GLOBAL MICROCATHETERSMARKET, BY END USER
9.1. Overview
9.2. Hospitals
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
9.3. Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
9.4. Specialized Clinics
Market Estimates & Forecast, by Region, 2018β2027
Market Estimates & Forecast, by Country, 2018β2027
10. GLOBAL MICROCATHETERSMARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. US
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. Italy
10.3.4. Spain
10.3.5. UK
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global MicrocathetersMarket
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global MicrocathetersMarket
11.7. Key Developments and Growth Strategies
11.7.1. New ProductLaunch/Service Deployment
11.7.2. Merger &Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2020
11.8.2. Major Players R&D Expenditure, 2020
12. COMPANY PROFILES
12.1. Medtronic
12.1.1. Company Overview
12.1.2. Product Offered
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Boston Scientific
12.2.1. Company Overview
12.2.2. Products Offered
12.2.3. Financial Overview
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Terumo Medical Corporation
12.3.1. Company Overview
12.3.2. Products Offered
12.3.3. Financial Overview
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Teleflex Inc.
12.4.1. Company Overview
12.4.2. Products Offered
12.4.3. Financial Overview
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Merit Medical Systems, Inc.
12.5.1. Company Overview
12.5.2. Products Offered
12.5.3. Financial Overview
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Guerbet
12.6.1. Company Overview
12.6.2. Products Offered
12.6.3. Financial Overview
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Cook Medical
12.7.1. Company Overview
12.7.2. Products Offered
12.7.3. Financial Overview
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Acandis GmbH
12.8.1. Company Overview
12.8.2. Products Offered
12.8.3. Financial Overview
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Acrostak
12.9.1. Company Overview
12.9.2. Products Offered
12.9.3. Financial Overview
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Stryker Corporation
12.10.1. Company Overview
12.10.2. Products Offered
12.10.3. Financial Overview
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Asahi Intecc
12.11.1. Company Overview
12.11.2. Products Offered
12.11.3. Financial Overview
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. Lepu Medical Technology Company
12.12.1. Company Overview
12.12.2. Products Offered
12.12.3. Financial Overview
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. Cerus Endovascular Ltd
12.13.1. Company Overview
12.13.2. Products Offered
12.13.3. Financial Overview
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
β
LIST OF TABLES
TABLE 1 GLOBAL MICROCATHETERSMARKET SYNOPSIS, 2018β2027
TABLE 2 GLOBAL MICROCATHETERSMARKET ESTIMATES &FORECAST, 2018β2027 (USD MILLION)
TABLE 3 GLOBAL MICROCATHETERSMARKET, BYDESIGN, 2018β2027 (USD MILLION)
TABLE 4 GLOBAL MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 5 GLOBAL MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION
TABLE 6 GLOBAL MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 7 NORTH AMERICA: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 8 NORTH AMERICA MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 9 NORTH AMERICA MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 10 NORTH AMERICA: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 11 US: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 12 US MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 13 US MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 14 US: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 15 CANADA: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 16 CANADA MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 17 CANADA MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 18 CANADA: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 19 EUROPE: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 20 EUROPE: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 21 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 22 EUROPE: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 23 GERMANY: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 24 GERMANY: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 25 GERMANY MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 26 GERMANY: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 27 UK: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 28 UK: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 29 UK MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 30 UK: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 31 FRANCE: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 32 FRANCE: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 33 FRANCE MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 34 FRANCE: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 35 ITALY: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 36 ITALY: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 37 ITALY MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 38 ITALY: MICROCATHETERS MARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 39 SPAIN: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 40 SPAIN: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 41 SPAIN MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 42 SPAIN: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 43 REST OF EUROPE: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 44 REST OF EUROPE: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 45 REST OF EUROPE MICROCATHETERS MARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 46 REST OF EUROPE: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 47 ASIA-PACIFIC: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 48 ASIA-PACIFIC: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 49 ASIA PACIFIC MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 50 ASIA-PACIFIC: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 51 INDIA: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 52 INDIA: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 53 INDIA MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 54 INDIA: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 55 CHINA: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 56 CHINA: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 57 CHINA MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 58 CHINA: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 59 JAPAN: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 60 JAPAN: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 61 JAPAN MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 62 JAPAN: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 63 SOUTH KOREA: MICROCATHETERS MARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 64 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 65 SOUTH KOREA MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 66 SOUTH KOREA: MICROCATHETERS MARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 67 AUSTRALIA: MICROCATHETERS MARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 69 AUSTRALIA MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 70 AUSTRALIA: MICROCATHETERS MARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 71 REST OF ASIA-PACIFIC: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 72 REST OF ASIA-PACIFIC: MICROCATHETERSMARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 73 REST OF ASIA-PACIFIC MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 74 REST OF ASIA-PACIFIC: MICROCATHETERSMARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 75 REST OF THE WORLD: MICROCATHETERSMARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 76 REST OF THE WORLD: MICROCATHETERSMARKET, PRODUCT2018β2027 (USD MILLION)
TABLE 77 REST OF THE WORLD: MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 78 REST OF THE WORLD: MICROCATHETERSMARKET, END USER, 2018β2027 (USD MILLION)
TABLE 79 MIDDLE EAST: MICROCATHETERS MARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 80 MIDDLE EAST: MICROCATHETERS MARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 81 MIDDLE EAST: MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 82 MIDDLE EAST: MICROCATHETERS MARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 83 AFRICA: MICROCATHETERS MARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 84 AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 85 AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 86 AFRICA: MICROCATHETERS MARKET, BY END USER, 2018β2027 (USD MILLION)
TABLE 87 LATIN AMERICA: MICROCATHETERS MARKET, BY DESIGN, 2018β2027 (USD MILLION)
TABLE 88 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2018β2027 (USD MILLION)
TABLE 89 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2018β2027 (USD MILLION)
TABLE 90 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2018β2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MICROCATHETERSMARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MICROCATHETERSMARKET
FIGURE 4 GLOBAL MICROCATHETERSMARKET SHARE, BY DESIGN, 2020 (%)
FIGURE 5 GLOBAL MICROCATHETERSMARKET SHARE, BY PRODUCT, 2020 (%)
FIGURE 6 GLOBAL MICROCATHETERS MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 7 GLOBAL MICROCATHETERSMARKET SHARE, BY END USER, 2020 (%)
FIGURE 8 GLOBAL MICROCATHETERSMARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: MICROCATHETERSMARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 EUROPE: MICROCATHETERSMARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 ASIA-PACIFIC: MICROCATHETERSMARKET SHARE, BY REGION, 2020 (%)
FIGURE 12 REST OF THE WORLD: MICROCATHETERSMARKET SHARE, BY REGION, 2020 (%)
FIGURE 13 GLOBAL MICROCATHETERSMARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 14 MEDTRONIC.: KEY FINANCIALS
FIGURE 15 MEDTRONIC: SEGMENTAL REVENUE
FIGURE 16 MEDTRONIC: REGIONAL REVENUE
FIGURE 17 BOSTON SCIENTIFIC: KEY FINANCIALS
FIGURE 18 BOSTON SCIENTIFIC: SEGMENTAL REVENUE
FIGURE 19 BOSTON SCIENTIFIC: REGIONAL REVENUE
FIGURE 20 TERUMO MEDICAL CORPORATION: KEY FINANCIALS
FIGURE 21 TERUMO MEDICAL CORPORATION: SEGMENTAL REVENUE
FIGURE 22 TERUMO MEDICAL CORPORATION: REGIONAL REVENUE
FIGURE 23 TELEFLEX INC.: KEY FINANCIALS
FIGURE 24 TELEFLEX INC.: SEGMENTAL REVENUE
FIGURE 25 TELEFLEX INC.: REGIONAL REVENUE
FIGURE 26 MERIT MEDICAL SYSTEMS, INC.: KEY FINANCIALS
FIGURE 27 MERIT MEDICAL SYSTEMS, INC.: SEGMENTAL REVENUE
FIGURE 28 MERIT MEDICAL SYSTEMS, INC.: REGIONAL REVENUE
FIGURE 29 COOK MEDICAL: KEY FINANCIALS
FIGURE 30 COOK MEDICAL: SEGMENTAL REVENUE
FIGURE 31 COOK MEDICAL: REGIONAL REVENUE
FIGURE 32 ACANDIS GMBH: KEY FINANCIALS
FIGURE 33 ACANDIS GMBH: SEGMENTAL REVENUE
FIGURE 34 ACANDIS GMBH: REGIONAL REVENUE
FIGURE 35 ACROSTAK: KEY FINANCIALS
FIGURE 36 ACROSTAK: SEGMENTAL REVENUE
FIGURE 37 ACROSTAK: REGIONAL REVENUE
FIGURE 38 STRYKER CORPORATION: KEY FINANCIALS
FIGURE 39 STRYKER CORPORATION: SEGMENTAL REVENUE
FIGURE 40 STRYKER CORPORATION: REGIONAL REVENUE
FIGURE 41 ASAHI INTECC: KEY FINANCIALS
FIGURE 42 ASAHI INTECC: SEGMENTAL REVENUE
FIGURE 43 ASAHI INTECC: REGIONAL REVENUE
FIGURE 44 LEPU MEDICAL TECHNOLOGY COMPANY: KEY FINANCIALS
FIGURE 45 LEPU MEDICAL TECHNOLOGY COMPANY: SEGMENTAL REVENUE
FIGURE 46 LEPU MEDICAL TECHNOLOGY COMPANY: REGIONAL REVENUE
FIGURE 47 CERUS ENDOVASCULAR LTD: KEY FINANCIALS
FIGURE 48 CERUS ENDOVASCULAR LTD: SEGMENTAL REVENUE
FIGURE 49 CERUS ENDOVASCULAR LTD: REGIONAL REVENUE
$2,412.0 million
4.1%
North America
2021-2027
The Microcatheters Market is expected to cross ~USD 2,412.0 million by 2027 at a CAGR of ~4.1% during the forecast period of 2021 to 2027.
Market Overview:
Microcatheters are the thin wall, small diameter catheters used in minimally invasive procedures, ideal for navigating the vast network of tiny veins found within the human body. These procedures are primarily employed in neurovascular and cardiovascular applications. They are most commonly used in selective applications where the anatomy would not be accessible via a standard catheter. Factors such as the rise in the prevalence of chronic diseases, includingneurovascular and cardiovascular disorders, increased adoption of minimally invasive procedures, and development of new diagnostic centers and hospitals in emerging economies are the key drivers ofthe global microcatheters market. There is an increasing preference for minimally invasive surgeries due to lower risk than traditional surgeries because they use smaller surgical incisions. Thus, all the above-mentioned factors are contributing to the growth of the microcatheter market.
In January 2021, Baylis Medical (Canada) launched the first clinical case in Europe of the JLL 2-French electrophysiology microcatheter. The JLL electrophysiology catheter was launched in partnership with Japan Lifeline Ltd (Japan), a leading Japanese cardiovascular device developer and manufacturer.Its family involves a 6F guiding catheter and a 2F microcatheter, which can be combined to allow deeper Coronary Sinus (CS) mapping. In August 2020, Cerus Endovascular Inc. (US) announced that it received FDA approval for its first microcatheter. Its 021 microcatheter is available in three different distal configurations.
COVID-19 Analysis
The COVID-19 pandemic has significantly impacted the number of surgical procedures performed.It has also led to workforce and staffing issues, changes in perioperative practices, and viral transmission risk intraoperatively. Many countries around the world made the necessary decisions to cancel all non-emergency surgical procedures to free up personnel and resources for COVID-19 patients. It is estimated that during the initial wave of COVID-19, at least 28 million elective operations were canceled. This significantly decreased the demand for microcatheters used for several surgical procedures.
The COVID-19 pandemic also had an impact on the operations of microcatheter manufacturers. Lockdowns had a negative impact on the supply chain and manufacturing facilities.This increased downward pressure on microcatheter production and demand.It also affected the import and export of medical devices.
Market Dynamics
Drivers
Increasing adoption of minimally invasive surgery
Market Opportunities
Increasing government funding for strengthening healthcare infrastructure
Market Restraints
Technology Analysis
Segment Overview
By Design
Single Lumen
Double Lumen
By Product
Aspiration Microcatheter
Delivery Microcatheter
Diagnostic Microcatheter
Steerable Microcatheter
Cardiovascular
Neurovascular
Peripheral Vascular
Oncology
Urology
Hospitals
Ambulatory Surgical Centers:
Specialized Clinics:
Regional Analysis
North America
Increasing acceptance of technologically advanced products across the region is driving the North America microcathetersmarket
Asia-Pacific
Increasing number of people suffering from chronic diseases is fueling the Asia-Pacificmicrocathetermarket
Competitive Landscape
List of companies with HQ
Recent Developments
Report Overview
Scope of the Report
Microcatheters Market, By Design
Microcatheters Market, By Product
Microcatheters Market, By Application
Microcatheters Market, By End User
Microcatheters Market, by Region
Report Attribute/Metric | Details |
---|---|
Market Size | 2027:~USD 9,500 Million |
CAGR | ~4.1% |
Base Year | 2020 |
Forecast Period | 2021-2027 |
Historical Data | 2017 & 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Design, Product, Application and End User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Medtronic (Ireland), Boston Scientific (US), Terumo Medical Corporation (US), Teleflex Inc. (US) Merit Medical Systems, Inc. (US), Guerbet (France), Cook Medical (US), Acandis GmbH (Germany), Acrostak (Switzerland) Stryker Corporation (US), Asahi Intecc (Japan), Lepu Medical Technology Company (China), Cerus Endovascular Ltd (US) |
Key Market Opportunities | β’ Technological advancements in the medical science β’ Increasing government funding for strengthening healthcare infrastructure |
Key Market Drivers | β’ Rise in the prevalence of chronic diseases such as neurovascular and cardiovascular disorders β’ Increasing adoption of minimally invasive surgery |